Seemantini Nadkarni, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lasers | 14 | 2021 | 952 | 4.010 |
Why?
|
Rheology | 9 | 2021 | 345 | 3.540 |
Why?
|
Blood Coagulation Tests | 3 | 2020 | 263 | 1.370 |
Why?
|
Optical Devices | 2 | 2020 | 37 | 1.200 |
Why?
|
Thrombelastography | 2 | 2020 | 164 | 1.070 |
Why?
|
Microscopy, Confocal | 2 | 2021 | 1970 | 1.030 |
Why?
|
Blood Coagulation | 3 | 2021 | 1127 | 1.000 |
Why?
|
Tomography, Optical Coherence | 11 | 2019 | 2657 | 0.980 |
Why?
|
Elasticity Imaging Techniques | 3 | 2013 | 388 | 0.870 |
Why?
|
Prothrombin Time | 2 | 2017 | 119 | 0.750 |
Why?
|
Mechanical Phenomena | 1 | 2021 | 140 | 0.730 |
Why?
|
Ultrasonography, Interventional | 5 | 2021 | 1486 | 0.710 |
Why?
|
Light | 3 | 2020 | 1374 | 0.710 |
Why?
|
Coronary Vessels | 12 | 2021 | 3107 | 0.680 |
Why?
|
Plaque, Atherosclerotic | 6 | 2019 | 1519 | 0.680 |
Why?
|
Fibrin | 1 | 2021 | 506 | 0.650 |
Why?
|
Scattering, Radiation | 3 | 2015 | 498 | 0.610 |
Why?
|
Hemorheology | 1 | 2017 | 145 | 0.590 |
Why?
|
Elastic Modulus | 5 | 2016 | 214 | 0.530 |
Why?
|
International Normalized Ratio | 1 | 2017 | 367 | 0.530 |
Why?
|
Hydrogels | 2 | 2020 | 724 | 0.520 |
Why?
|
Coronary Artery Disease | 11 | 2021 | 6486 | 0.490 |
Why?
|
Blood Coagulation Disorders | 1 | 2017 | 337 | 0.480 |
Why?
|
Atherosclerosis | 5 | 2008 | 3444 | 0.470 |
Why?
|
Point-of-Care Systems | 2 | 2019 | 1178 | 0.450 |
Why?
|
Laser Therapy | 1 | 2019 | 1072 | 0.410 |
Why?
|
Aorta | 3 | 2011 | 2062 | 0.410 |
Why?
|
Body Fluids | 1 | 2013 | 319 | 0.400 |
Why?
|
Biosensing Techniques | 1 | 2017 | 668 | 0.390 |
Why?
|
Particle Size | 1 | 2015 | 1642 | 0.370 |
Why?
|
Tomography, Optical | 1 | 2011 | 126 | 0.360 |
Why?
|
Catheters | 2 | 2021 | 425 | 0.340 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3590 | 0.340 |
Why?
|
Collagen | 2 | 2008 | 2688 | 0.330 |
Why?
|
Warfarin | 1 | 2017 | 1497 | 0.330 |
Why?
|
Acute Coronary Syndrome | 2 | 2019 | 2337 | 0.330 |
Why?
|
Image Enhancement | 5 | 2013 | 2921 | 0.330 |
Why?
|
Refractometry | 1 | 2008 | 56 | 0.320 |
Why?
|
Technology | 2 | 2021 | 304 | 0.320 |
Why?
|
Hemorrhage | 1 | 2020 | 3461 | 0.320 |
Why?
|
Rupture, Spontaneous | 3 | 2019 | 354 | 0.310 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2013 | 3326 | 0.310 |
Why?
|
Phantoms, Imaging | 6 | 2013 | 2480 | 0.300 |
Why?
|
Fiber Optic Technology | 1 | 2008 | 290 | 0.290 |
Why?
|
Viscosity | 3 | 2016 | 328 | 0.280 |
Why?
|
Algorithms | 6 | 2021 | 13882 | 0.270 |
Why?
|
Cardiac Surgical Procedures | 1 | 2021 | 3537 | 0.270 |
Why?
|
Artifacts | 4 | 2013 | 1904 | 0.260 |
Why?
|
Echocardiography, Three-Dimensional | 2 | 2001 | 591 | 0.250 |
Why?
|
Models, Cardiovascular | 2 | 2019 | 996 | 0.250 |
Why?
|
Elasticity | 2 | 2016 | 657 | 0.230 |
Why?
|
Imaging, Three-Dimensional | 3 | 2006 | 4042 | 0.230 |
Why?
|
Biophysics | 2 | 2021 | 383 | 0.220 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2021 | 8949 | 0.220 |
Why?
|
Muscle, Smooth | 1 | 2007 | 934 | 0.220 |
Why?
|
Neoplasms | 2 | 2021 | 21696 | 0.210 |
Why?
|
Anticoagulants | 1 | 2017 | 4600 | 0.210 |
Why?
|
Swine | 6 | 2020 | 5918 | 0.210 |
Why?
|
Reproducibility of Results | 9 | 2020 | 19905 | 0.200 |
Why?
|
Cadaver | 4 | 2017 | 1337 | 0.180 |
Why?
|
Predictive Value of Tests | 8 | 2020 | 15078 | 0.180 |
Why?
|
Scanning Laser Polarimetry | 1 | 2019 | 5 | 0.180 |
Why?
|
Aortic Diseases | 1 | 2006 | 743 | 0.180 |
Why?
|
Bacterial Adhesion | 1 | 2020 | 316 | 0.170 |
Why?
|
Carotid Stenosis | 1 | 2006 | 854 | 0.160 |
Why?
|
Tensile Strength | 1 | 2019 | 335 | 0.160 |
Why?
|
Equipment Failure Analysis | 2 | 2011 | 868 | 0.150 |
Why?
|
Partial Thromboplastin Time | 1 | 2017 | 206 | 0.140 |
Why?
|
Fibrosis | 3 | 2019 | 2029 | 0.140 |
Why?
|
Microscopy, Atomic Force | 1 | 2016 | 250 | 0.140 |
Why?
|
Necrosis | 1 | 2019 | 1643 | 0.120 |
Why?
|
Viscoelastic Substances | 1 | 2014 | 19 | 0.120 |
Why?
|
Humans | 30 | 2021 | 744366 | 0.120 |
Why?
|
Suspensions | 1 | 2014 | 65 | 0.120 |
Why?
|
Dimethylpolysiloxanes | 1 | 2015 | 149 | 0.120 |
Why?
|
Absorption | 1 | 2014 | 248 | 0.120 |
Why?
|
Blood Viscosity | 1 | 2014 | 124 | 0.120 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 301 | 0.120 |
Why?
|
Stress, Mechanical | 1 | 2019 | 1686 | 0.120 |
Why?
|
Drug-Eluting Stents | 1 | 2020 | 753 | 0.120 |
Why?
|
Glycerol | 1 | 2013 | 278 | 0.100 |
Why?
|
Sensitivity and Specificity | 5 | 2013 | 14723 | 0.100 |
Why?
|
Equipment Design | 2 | 2011 | 3582 | 0.100 |
Why?
|
Vitreous Body | 1 | 2013 | 389 | 0.100 |
Why?
|
Synovial Fluid | 1 | 2013 | 394 | 0.100 |
Why?
|
Titanium | 1 | 2013 | 494 | 0.090 |
Why?
|
Shear Strength | 1 | 2011 | 165 | 0.090 |
Why?
|
Models, Theoretical | 1 | 2021 | 3589 | 0.080 |
Why?
|
Photons | 1 | 2013 | 588 | 0.080 |
Why?
|
Carotid Arteries | 1 | 2013 | 950 | 0.080 |
Why?
|
Risk Assessment | 2 | 2020 | 23336 | 0.080 |
Why?
|
Catheterization | 1 | 2013 | 1470 | 0.080 |
Why?
|
Cattle | 1 | 2013 | 3922 | 0.070 |
Why?
|
Time Factors | 3 | 2020 | 40075 | 0.070 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11031 | 0.070 |
Why?
|
Water | 1 | 2013 | 1395 | 0.070 |
Why?
|
Heart | 1 | 2000 | 4464 | 0.070 |
Why?
|
Medical Records | 1 | 2012 | 1413 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.060 |
Why?
|
Endovascular Procedures | 1 | 2018 | 1980 | 0.060 |
Why?
|
Animals | 8 | 2020 | 168768 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2005 | 6366 | 0.060 |
Why?
|
Pulsatile Flow | 1 | 2005 | 332 | 0.060 |
Why?
|
Risk Factors | 2 | 2020 | 72296 | 0.050 |
Why?
|
Contrast Media | 1 | 2015 | 5300 | 0.050 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2008 | 1504 | 0.050 |
Why?
|
Silver | 1 | 2020 | 122 | 0.040 |
Why?
|
Stents | 3 | 2020 | 3282 | 0.040 |
Why?
|
Neointima | 1 | 2020 | 135 | 0.040 |
Why?
|
Transducers | 1 | 2001 | 252 | 0.040 |
Why?
|
Biophysical Phenomena | 1 | 2000 | 327 | 0.040 |
Why?
|
Birefringence | 1 | 2018 | 56 | 0.040 |
Why?
|
Observer Variation | 2 | 2006 | 2593 | 0.040 |
Why?
|
Electrocardiography | 2 | 2015 | 6442 | 0.040 |
Why?
|
Tunica Intima | 2 | 2012 | 464 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3508 | 0.040 |
Why?
|
Female | 6 | 2021 | 380193 | 0.030 |
Why?
|
Male | 4 | 2021 | 350115 | 0.030 |
Why?
|
Radiography | 1 | 2005 | 7023 | 0.030 |
Why?
|
Angioscopy | 1 | 2011 | 49 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2019 | 77460 | 0.020 |
Why?
|
Spectrum Analysis, Raman | 1 | 2011 | 247 | 0.020 |
Why?
|
Spectrometry, Fluorescence | 1 | 2011 | 688 | 0.020 |
Why?
|
Coronary Circulation | 1 | 2015 | 1572 | 0.020 |
Why?
|
Coronary Thrombosis | 1 | 2012 | 495 | 0.020 |
Why?
|
Models, Animal | 1 | 2015 | 2173 | 0.020 |
Why?
|
Reference Standards | 1 | 2012 | 1025 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2000 | 3817 | 0.020 |
Why?
|
Echocardiography | 1 | 2000 | 5099 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8319 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2011 | 721 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6755 | 0.020 |
Why?
|
International Cooperation | 1 | 2012 | 1420 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2011 | 3144 | 0.020 |
Why?
|
Leukocytes | 1 | 2011 | 2045 | 0.010 |
Why?
|
Cholesterol | 1 | 2011 | 2919 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3611 | 0.010 |
Why?
|
Ultrasonography | 1 | 2012 | 5984 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 25039 | 0.010 |
Why?
|
Calcium | 1 | 2011 | 5755 | 0.010 |
Why?
|
Calcinosis | 1 | 2006 | 1499 | 0.010 |
Why?
|
Middle Aged | 2 | 2019 | 213390 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 63107 | 0.010 |
Why?
|
Aged | 1 | 2019 | 163288 | 0.000 |
Why?
|